Cancer: Indicting Krebiozen

After 131 years of medical claims and counterclaims, of whodunit-style charges and countercharges, the loud controversy over the alleged anti-cancer drug Krebiozen seemed headed at last toward orderly disposition. A federal grand jury in Chicago handed up an 85-page indictment listing 49 counts against Dr. Andrew C. Ivy, 71, three associates and a corporation. The charges ranged from mail fraud and conspiracy to mislabeling and making false statements to Government agencies about the drug.

No fewer than 44 of the counts named Dr. Ivy himself, a noted physiologist who was formerly the...

Want the full story?

Subscribe Now


Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!